A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2020; you can also visit the original URL.
The file type is application/pdf
.
Mitral Valve Replacement in Severe Pulmonary Artery Hypertension — a Single Center Single Surgeon Experience
2018
Annals of International medical and Dental Research
Pulmonary artery hypertension (PAH) is a major risk factor in patients presenting in our hospital for mitral valve replacement (MVR) surgery. In this prospective study, we have focused on hemodynamic changes and postoperative results of MVR in patients with severe PAH. Methods: 136 consecutive patients who underwent mitral valve replacement for severe rheumatic mitral valve disease with severe PAH (pulmonary artery pressure (PAP) > 50 mmHg) were studied prospectively for immediate postoperative
doi:10.21276/aimdr.2018.4.3.me7
fatcat:fvjyhd37ffhttdbxvgkza3fxii